Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Eyelash Hypotrichosis
Interventions
DRUG

bimatoprost ophthalmic solution 0.005%

One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)

DRUG

bimatoprost ophthalmic solution 0.015%

One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)

DRUG

bimatoprost ophthalmic solution 0.03%

One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margins (where the eyelashes meet the skin)

Trial Locations (1)

Unknown

San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY